Phosphates de calcium : Questions médicales fréquentes
Nom anglais: Calcium Phosphates
Descriptor UI:D002130
Tree Number:D01.695.625.675.650.075
Termes MeSH sélectionnés :
Connective Tissue
Questions fréquentes et termes MeSH associés
Diagnostic
5
#1
Comment diagnostiquer une carence en phosphates de calcium ?
Un diagnostic se fait par des analyses sanguines mesurant les niveaux de calcium et de phosphates.
Carence en calciumPhosphates
#2
Quels tests sont utilisés pour évaluer les phosphates de calcium ?
Les tests sanguins et urinaires mesurent les niveaux de calcium et de phosphates.
Tests de laboratoireCalcium
#3
Quels symptômes indiquent un excès de phosphates de calcium ?
Des symptômes comme des douleurs osseuses, des démangeaisons et des troubles digestifs peuvent apparaître.
HyperphosphatémieSymptômes
#4
Comment évaluer la santé osseuse liée aux phosphates ?
Des examens d'imagerie comme la densitométrie osseuse peuvent être réalisés.
Densitométrie osseuseSanté osseuse
#5
Quels marqueurs biologiques sont liés aux phosphates de calcium ?
Les niveaux de parathormone et de vitamine D sont des marqueurs importants à surveiller.
ParathormoneVitamine D
Symptômes
5
#1
Quels sont les symptômes d'une carence en phosphates de calcium ?
Les symptômes incluent des douleurs osseuses, des faiblesses musculaires et des fractures fréquentes.
Carence en calciumDouleurs osseuses
#2
Comment reconnaître une hyperphosphatémie ?
Des démangeaisons, des douleurs articulaires et des éruptions cutanées peuvent survenir.
HyperphosphatémieSymptômes
#3
Quels signes indiquent un déséquilibre phosphocalcique ?
Des signes incluent des crampes musculaires, des troubles de la croissance et des anomalies dentaires.
Déséquilibre électrolytiqueCroissance
#4
Quels symptômes sont liés à une surconsommation de phosphates ?
Une surconsommation peut entraîner des nausées, des vomissements et des douleurs abdominales.
SurconsommationNausées
#5
Quels symptômes peuvent affecter les reins ?
Une accumulation de phosphates peut causer des douleurs rénales et des calculs rénaux.
Calculs rénauxDouleurs rénales
Prévention
5
#1
Comment prévenir une carence en phosphates de calcium ?
Une alimentation équilibrée riche en produits laitiers et légumes verts est essentielle.
PréventionAlimentation
#2
Quels conseils nutritionnels pour éviter l'hyperphosphatémie ?
Limiter les aliments riches en phosphates et augmenter l'hydratation peut aider.
NutritionHydratation
#3
Comment le mode de vie influence-t-il les niveaux de phosphates ?
Un mode de vie actif et une bonne hydratation favorisent un équilibre phosphocalcique.
Mode de vieHydratation
#4
Quels exercices sont bénéfiques pour la santé osseuse ?
Des exercices de résistance et de port de poids renforcent les os et améliorent la santé.
ExerciceSanté osseuse
#5
Comment surveiller les niveaux de phosphates chez les patients à risque ?
Des contrôles réguliers des niveaux sanguins de calcium et de phosphates sont recommandés.
SurveillanceRisque
Traitements
5
#1
Comment traiter une carence en phosphates de calcium ?
Le traitement inclut des suppléments de phosphates et une alimentation riche en calcium.
Suppléments de calciumAlimentation
#2
Quels médicaments sont utilisés pour l'hyperphosphatémie ?
Des chélateurs de phosphates et des médicaments à base de calcium peuvent être prescrits.
ChélateursMédicaments
#3
Comment gérer les déséquilibres phosphocalciques ?
La gestion implique des ajustements alimentaires et des traitements médicaux adaptés.
Gestion des déséquilibresAlimentation
#4
Quels traitements sont efficaces pour les douleurs osseuses ?
Des analgésiques et des anti-inflammatoires peuvent soulager les douleurs osseuses.
AnalgésiquesAnti-inflammatoires
#5
Comment prévenir les complications liées aux phosphates ?
Un suivi régulier et une alimentation équilibrée aident à prévenir les complications.
PréventionComplications
Complications
5
#1
Quelles complications peuvent survenir avec une carence en phosphates ?
Des complications incluent des fractures osseuses, des déformations et des douleurs chroniques.
ComplicationsFractures
#2
Quels risques sont associés à l'hyperphosphatémie ?
L'hyperphosphatémie peut entraîner des calcifications des tissus et des maladies rénales.
HyperphosphatémieMaladies rénales
#3
Comment les déséquilibres phosphocalciques affectent-ils la santé ?
Ils peuvent provoquer des troubles osseux, des douleurs et des problèmes métaboliques.
DéséquilibresSanté
#4
Quelles sont les complications à long terme d'une mauvaise gestion ?
Une mauvaise gestion peut entraîner des maladies osseuses chroniques et des douleurs persistantes.
Maladies chroniquesGestion
#5
Quels effets l'excès de phosphates a-t-il sur le cœur ?
Un excès de phosphates peut augmenter le risque de maladies cardiovasculaires.
Maladies cardiovasculairesExcès
Facteurs de risque
5
#1
Quels facteurs augmentent le risque de carence en phosphates ?
Les régimes alimentaires pauvres, certaines maladies et des médicaments peuvent augmenter le risque.
Facteurs de risqueRégime alimentaire
#2
Comment l'âge influence-t-il les niveaux de phosphates ?
Avec l'âge, l'absorption des phosphates peut diminuer, augmentant le risque de carence.
ÂgeAbsorption
#3
Quels médicaments peuvent affecter les niveaux de phosphates ?
Certains diurétiques et médicaments antiacides peuvent perturber l'équilibre phosphocalcique.
MédicamentsDiurétiques
#4
Comment les maladies rénales influencent-elles les phosphates ?
Les maladies rénales peuvent entraîner une rétention de phosphates, augmentant le risque d'hyperphosphatémie.
Maladies rénalesHyperphosphatémie
#5
Quels comportements alimentaires sont des facteurs de risque ?
Une consommation excessive de produits transformés riches en phosphates est un facteur de risque.
Comportements alimentairesProduits transformés
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Phosphates de calcium : Questions médicales les plus fréquentes",
"headline": "Phosphates de calcium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Phosphates de calcium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-24",
"dateModified": "2025-03-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Phosphates de calcium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phosphates",
"url": "https://questionsmedicales.fr/mesh/D010710",
"about": {
"@type": "MedicalCondition",
"name": "Phosphates",
"code": {
"@type": "MedicalCode",
"code": "D010710",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apatites",
"alternateName": "Apatites",
"url": "https://questionsmedicales.fr/mesh/D001031",
"about": {
"@type": "MedicalCondition",
"name": "Apatites",
"code": {
"@type": "MedicalCode",
"code": "D001031",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hydroxyapatites",
"alternateName": "Hydroxyapatites",
"url": "https://questionsmedicales.fr/mesh/D006882",
"about": {
"@type": "MedicalCondition",
"name": "Hydroxyapatites",
"code": {
"@type": "MedicalCode",
"code": "D006882",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Durapatite",
"alternateName": "Durapatite",
"url": "https://questionsmedicales.fr/mesh/D017886",
"about": {
"@type": "MedicalCondition",
"name": "Durapatite",
"code": {
"@type": "MedicalCode",
"code": "D017886",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025.300.150"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Durapatite",
"alternateName": "Durapatite",
"url": "https://questionsmedicales.fr/mesh/D017886",
"about": {
"@type": "MedicalCondition",
"name": "Durapatite",
"code": {
"@type": "MedicalCode",
"code": "D017886",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.695.625.675.650.075.025.300.150"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Phosphates de calcium",
"alternateName": "Calcium Phosphates",
"code": {
"@type": "MedicalCode",
"code": "D002130",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Helmut Cölfen",
"url": "https://questionsmedicales.fr/author/Helmut%20C%C3%B6lfen",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Universitätsstrasse 10, Box 714, 78457 Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "Hockin H K Xu",
"url": "https://questionsmedicales.fr/author/Hockin%20H%20K%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Center for Stem Cell Biology & Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America; Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America. Electronic address: HXu2@umaryland.edu."
}
},
{
"@type": "Person",
"name": "Michael D Weir",
"url": "https://questionsmedicales.fr/author/Michael%20D%20Weir",
"affiliation": {
"@type": "Organization",
"name": "Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America. Electronic address: michael.weir@umaryland.edu."
}
},
{
"@type": "Person",
"name": "Abhishek Indurkar",
"url": "https://questionsmedicales.fr/author/Abhishek%20Indurkar",
"affiliation": {
"@type": "Organization",
"name": "Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia."
}
},
{
"@type": "Person",
"name": "Rajan Choudhary",
"url": "https://questionsmedicales.fr/author/Rajan%20Choudhary",
"affiliation": {
"@type": "Organization",
"name": "Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Is connective tissue massage effective in individuals with fibromyalgia?",
"datePublished": "2023-12-27",
"url": "https://questionsmedicales.fr/article/38763557",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbmt.2023.09.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacological Therapies for Connective Tissue Fibrosis in Orthopaedics.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35970181",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/03635465221116358"
}
},
{
"@type": "ScholarlyArticle",
"name": "Developmental Foot Deformities in Patients with Connective Tissue Disorders.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800486",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2106/JBJS.RVW.22.00219"
}
},
{
"@type": "ScholarlyArticle",
"name": "The association between keratoconus and systemic manifestations of connective tissue hyperlaxity.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37479535",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clae.2023.101892"
}
},
{
"@type": "ScholarlyArticle",
"name": "A new conceptual model for anorexia nervosa: A role for connective tissue?",
"datePublished": "2024-02-19",
"url": "https://questionsmedicales.fr/article/38372082",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/eat.24172"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Produits chimiques inorganiques",
"item": "https://questionsmedicales.fr/mesh/D007287"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du phosphore",
"item": "https://questionsmedicales.fr/mesh/D017553"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides du phosphore",
"item": "https://questionsmedicales.fr/mesh/D017976"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides phosphoriques",
"item": "https://questionsmedicales.fr/mesh/D010756"
},
{
"@type": "ListItem",
"position": 6,
"name": "Phosphates",
"item": "https://questionsmedicales.fr/mesh/D010710"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phosphates de calcium",
"item": "https://questionsmedicales.fr/mesh/D002130"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Phosphates de calcium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Phosphates de calcium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Phosphates de calcium",
"description": "Comment diagnostiquer une carence en phosphates de calcium ?\nQuels tests sont utilisés pour évaluer les phosphates de calcium ?\nQuels symptômes indiquent un excès de phosphates de calcium ?\nComment évaluer la santé osseuse liée aux phosphates ?\nQuels marqueurs biologiques sont liés aux phosphates de calcium ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Connective+Tissue#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Phosphates de calcium",
"description": "Quels sont les symptômes d'une carence en phosphates de calcium ?\nComment reconnaître une hyperphosphatémie ?\nQuels signes indiquent un déséquilibre phosphocalcique ?\nQuels symptômes sont liés à une surconsommation de phosphates ?\nQuels symptômes peuvent affecter les reins ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Connective+Tissue#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Phosphates de calcium",
"description": "Comment prévenir une carence en phosphates de calcium ?\nQuels conseils nutritionnels pour éviter l'hyperphosphatémie ?\nComment le mode de vie influence-t-il les niveaux de phosphates ?\nQuels exercices sont bénéfiques pour la santé osseuse ?\nComment surveiller les niveaux de phosphates chez les patients à risque ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Connective+Tissue#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Phosphates de calcium",
"description": "Comment traiter une carence en phosphates de calcium ?\nQuels médicaments sont utilisés pour l'hyperphosphatémie ?\nComment gérer les déséquilibres phosphocalciques ?\nQuels traitements sont efficaces pour les douleurs osseuses ?\nComment prévenir les complications liées aux phosphates ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Connective+Tissue#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Phosphates de calcium",
"description": "Quelles complications peuvent survenir avec une carence en phosphates ?\nQuels risques sont associés à l'hyperphosphatémie ?\nComment les déséquilibres phosphocalciques affectent-ils la santé ?\nQuelles sont les complications à long terme d'une mauvaise gestion ?\nQuels effets l'excès de phosphates a-t-il sur le cœur ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Connective+Tissue#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Phosphates de calcium",
"description": "Quels facteurs augmentent le risque de carence en phosphates ?\nComment l'âge influence-t-il les niveaux de phosphates ?\nQuels médicaments peuvent affecter les niveaux de phosphates ?\nComment les maladies rénales influencent-elles les phosphates ?\nQuels comportements alimentaires sont des facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D002130?mesh_terms=Connective+Tissue#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en phosphates de calcium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des analyses sanguines mesurant les niveaux de calcium et de phosphates."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les phosphates de calcium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins et urinaires mesurent les niveaux de calcium et de phosphates."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un excès de phosphates de calcium ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs osseuses, des démangeaisons et des troubles digestifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment évaluer la santé osseuse liée aux phosphates ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme la densitométrie osseuse peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont liés aux phosphates de calcium ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de parathormone et de vitamine D sont des marqueurs importants à surveiller."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en phosphates de calcium ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs osseuses, des faiblesses musculaires et des fractures fréquentes."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hyperphosphatémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, des douleurs articulaires et des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un déséquilibre phosphocalcique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des crampes musculaires, des troubles de la croissance et des anomalies dentaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une surconsommation de phosphates ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des nausées, des vomissements et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent affecter les reins ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une accumulation de phosphates peut causer des douleurs rénales et des calculs rénaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en phosphates de calcium ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en produits laitiers et légumes verts est essentielle."
}
},
{
"@type": "Question",
"name": "Quels conseils nutritionnels pour éviter l'hyperphosphatémie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter les aliments riches en phosphates et augmenter l'hydratation peut aider."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il les niveaux de phosphates ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie actif et une bonne hydratation favorisent un équilibre phosphocalcique."
}
},
{
"@type": "Question",
"name": "Quels exercices sont bénéfiques pour la santé osseuse ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices de résistance et de port de poids renforcent les os et améliorent la santé."
}
},
{
"@type": "Question",
"name": "Comment surveiller les niveaux de phosphates chez les patients à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers des niveaux sanguins de calcium et de phosphates sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en phosphates de calcium ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments de phosphates et une alimentation riche en calcium."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour l'hyperphosphatémie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des chélateurs de phosphates et des médicaments à base de calcium peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Comment gérer les déséquilibres phosphocalciques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique des ajustements alimentaires et des traitements médicaux adaptés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour les douleurs osseuses ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des anti-inflammatoires peuvent soulager les douleurs osseuses."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux phosphates ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et une alimentation équilibrée aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en phosphates ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des fractures osseuses, des déformations et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'hyperphosphatémie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperphosphatémie peut entraîner des calcifications des tissus et des maladies rénales."
}
},
{
"@type": "Question",
"name": "Comment les déséquilibres phosphocalciques affectent-ils la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles osseux, des douleurs et des problèmes métaboliques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme d'une mauvaise gestion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise gestion peut entraîner des maladies osseuses chroniques et des douleurs persistantes."
}
},
{
"@type": "Question",
"name": "Quels effets l'excès de phosphates a-t-il sur le cœur ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès de phosphates peut augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en phosphates ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les régimes alimentaires pauvres, certaines maladies et des médicaments peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les niveaux de phosphates ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avec l'âge, l'absorption des phosphates peut diminuer, augmentant le risque de carence."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent affecter les niveaux de phosphates ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains diurétiques et médicaments antiacides peuvent perturber l'équilibre phosphocalcique."
}
},
{
"@type": "Question",
"name": "Comment les maladies rénales influencent-elles les phosphates ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies rénales peuvent entraîner une rétention de phosphates, augmentant le risque d'hyperphosphatémie."
}
},
{
"@type": "Question",
"name": "Quels comportements alimentaires sont des facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation excessive de produits transformés riches en phosphates est un facteur de risque."
}
}
]
}
]
}
Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Center for Stem Cell Biology & Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America; Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America. Electronic address: HXu2@umaryland.edu.
Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America. Electronic address: michael.weir@umaryland.edu.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Rudolfs Cimdins Riga Biomaterials Innovations and Development Centre of RTU, Institute of General Chemical Engineering, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Pulka Street 3, LV-1007 Riga, Latvia.
Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Kipsalas Street 6A, LV-1048 Riga, Latvia.
Division of Operative Dentistry, Department of General Dentistry, University of Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America.
Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America.
Department of Advanced Production Engineering, Engineering and Technology Institute Groningen, Faculty of Science and Engineering , University of Groningen , Nijenborgh 4 , 9747 AG Groningen , The Netherlands.
Department of Biomedical Engineering-FB40, W.J. Kolff Institute for Biomedical Engineering and Materials Science-FB41, University Medical Center Groningen , University of Groningen , A. Deusinglaan 1 , 9713 AV Groningen , The Netherlands.
Department of Advanced Production Engineering, Engineering and Technology Institute Groningen, Faculty of Science and Engineering , University of Groningen , Nijenborgh 4 , 9747 AG Groningen , The Netherlands.
The aim of the study was to examine the effectiveness of Clinical Pilates exercises and connective tissue massage (CTM) in individuals with Fibromyalgia (FM) on pain, disease impact, functional status...
32 women were randomly divided into two groups as intervention gorup (CTM + Clinical Pilates exercises, n = 15, mean age = 48.80 ± 7.48) and control gorup (Clinical Pilates exercises, n = 17, mean age...
When the pre-treatment and post-treatment results are analyzed; significant difference was observed in PLI (p = 0.007; effect size 1.273), FIQ (p = 0.004; effect size 0.987), SF-36 physical component ...
CTM can be effective in reducing the number of painful areas in addition to the positive effects of clinical Pilates exercises in women with FM....
Fibrosis is a common and debilitating pathological process that affects many organ systems and contributes to connective tissue disorders in orthopaedics. Tendons heal after acute and chronic injury t...
Foot deformities make up a large percentage of all orthopaedic complaints in patients with Down syndrome, Marfan syndrome, Ehlers-Danlos syndrome, Larsen syndrome, and osteogenesis imperfecta....
Some common causes of foot deformities in these conditions include increased ligament laxity, hypotonia, and hypermobility of the joints....
Treatment options for syndromic foot deformities include the use of foot orthoses, physical therapy, bracing, and various surgical procedures....
There is limited evidence supporting the use of surgical intervention to correct foot deformities associated with Down syndrome, Marfan syndrome, Ehlers-Danlos syndrome, Larsen syndrome, and osteogene...
To evaluate the correlation between keratoconus and systemic manifestations of tissue hyperlaxity in the general population....
In this population based cross-sectional study 940,763 medical records of Israeli adolescents and young adults in military service were reviewed. Demographic and medical data were extracted. The preva...
Overall 938,411 adolescents and adults were included. Mean age was 17.55 ± 1.50 years, and 40.70% were female. Keratoconus was documented in 1,529 cases, with a prevalence of 0.16%. Compared to the ge...
In this large cohort of adolescents and young adults, an association was found between keratoconus and connective tissue hyperlaxity manifestations involving the knees, feet, spine and abdomen. These ...
The etiology of anorexia nervosa (AN) remains to be fully elucidated, and current theories also fail to account for the direct effect of starvation on the health of the organs and tissues, specificall...
Multiple cases of autoimmune and autoinflammatory diseases after COVID-19 have been reported. However, their incidences and risks have rarely been quantified....
To investigate the incidences and risks of autoimmune and autoinflammatory connective tissue disorders after COVID-19....
This was a retrospective population-based study conducted between October 8, 2020, and December 31, 2021, that used nationwide data from the Korea Disease Control and Prevention Agency COVID-19 Nation...
Receipt of diagnosis of COVID-19....
The primary outcomes were the incidence and risk of autoimmune and autoinflammatory connective tissue disorders following COVID-19. A total of 32 covariates, including demographics, socioeconomic stat...
A total of 354 527 individuals with COVID-19 (mean [SD] age, 52.24 [15.55] years; 179 041 women [50.50%]) and 6 134 940 controls (mean [SD] age, 52.05 [15.63] years; 3 074 573 women [50.12%]) were inc...
In this retrospective cohort study, COVID-19 was associated with a substantial risk for autoimmune and autoinflammatory connective tissue disorders, indicating that long-term management of patients wi...
Dental implants are now one of the most useful therapies worldwide with higher rates of success from simple to complex cases, but also, with different results regarding the esthetics, cost and long-te...
Anecdotally, fibromyalgia syndrome (FMS) and connective tissue disorders (hypermobile Ehlers-Danlos Syndrome (hEDS), Hypermobility Spectrum disorders (HSD) and Generalized Joint Hypermobility (GJH)) m...
MEDLINE (via EBSCO host) was systematically searched. Observational research (case-control or single group) studies were considered for inclusion, where adults screened for hEDS/HSD/GJH and FMS were c...
The review included eleven studies: nine case-control studies and two single group studies. The prevalence of concomitant diagnosis of hEDS/HSD and FMS ranged from 68%-88.9% and from 8.0 to 64.2% for ...
There may be overlapping symptomatology and diagnostic prevalence of FMS and hEDS/HSD/GJH. Clinicians should consider both diagnoses to ensure appropriate diagnosis and management....
The durability of reimplanted myxomatous aortic valves in root replacements for patients with connective tissue disorders (CTD) is unclear; therefore, we sought to evaluate the long-term resilience of...
From January 1980 to January 2020, 214 patients with CTD and 645 without CTD underwent primary, elective aortic valve reimplantation operations at Cleveland Clinic. The CTD cohort included 164 (77%) w...
In the CTD cohort, there were no operative mortalities (30-day or in-hospital), 1 (0.47%) stroke, and 1 (0.47%) early in-hospital reoperation for valve dysfunction. Ten-year prevalence of no aortic re...
Aortic valve reimplantation is a durable operation in patients with CTD and root aneurysms. These patients do not experience early degeneration of their reimplanted aortic valves....
Lesion formation after soft tissue gingival grafting is a rare but challenging clinical scenario to manage. This report presents a unique case of cyst formation after connective tissue grafting. All p...